FBXW7 modulates malignant potential and cisplatin‐induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1
Open Access
- 9 October 2018
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 109 (12) , 3883-3895
Abstract
The ubiquitin ligase F‐box and WD repeat domain‐containing 7 (FBXW7) is responsible for degrading diverse oncoproteins and is considered a tumor suppressor in many human cancers. Inhibiting FBXW7 enhances the malignant potential of several cancers. In this study, we aimed to investigate the role of FBXW7 in cholangiocarcinoma. We found that FBXW7 expression was associated with clinicopathological outcomes in cholangiocarcinoma patients. Both disease‐free and overall survival were significantly worse in the low‐FBXW7 group than in the high‐FBXW7 group (P = .001 and P < .001, respectively). Multivariate analysis with the Cox proportional hazards model indicated that FBXW7 was the most important independent prognostic factor for disease‐free (P = .006) and overall (P = .0004) survival. We also showed that the two FBXW7 substrates, NOTCH1 and myeloid cell leukemia sequence 1 (MCL1), regulate cholangiocarcinoma progression. Depletion of FBXW7 resulted in NOTCH1 accumulation and increased cholangiocarcinoma cell migration and self‐renewal. Interestingly, when cells were stimulated with cis‐diamminedichloridoplatinum(II) (cisplatin), FBXW7 suppression induced MCL1 upregulation, which reduced the sensitivity of cholangiocarcinoma cells to apoptosis, indicating that FBXW7‐mediated ubiquitylation is context‐dependent. These results indicate that FBXW7 modulates the malignant potential of cholangiocarcinoma through independent regulation of NOTCH1 and MCL1.Keywords
Funding Information
- Japan Society for the Promotion of Science (16K19910, 26861058)
This publication has 50 references indexed in Scilit:
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Risk factors for cholangiocarcinomaHepatology, 2011
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destructionNature, 2011
- The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasisThe EMBO Journal, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor SuppressionScience, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersNature, 2007
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004